Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$71.48 - $86.85 $15.1 Million - $18.4 Million
-211,326 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$74.28 - $92.69 $419,756 - $523,791
-5,651 Reduced 2.6%
211,326 $16.3 Million
Q4 2021

Feb 14, 2022

BUY
$71.72 - $91.47 $4.87 Million - $6.22 Million
67,960 Added 45.61%
216,977 $19.2 Million
Q3 2021

Nov 15, 2021

BUY
$74.77 - $85.47 $11.1 Million - $12.7 Million
149,017 New
149,017 $11.5 Million
Q1 2020

May 14, 2020

SELL
$71.37 - $96.85 $17.9 Million - $24.3 Million
-251,382 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$64.27 - $86.37 $16.2 Million - $21.7 Million
251,382 New
251,382 $21.3 Million
Q4 2018

Feb 14, 2019

SELL
$80.14 - $106.07 $7.05 Million - $9.33 Million
-88,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$93.92 - $105.72 $7.68 Million - $8.64 Million
81,750 Added 1308.0%
88,000 $8.53 Million
Q2 2018

Aug 13, 2018

BUY
$76.01 - $99.03 $475,062 - $618,937
6,250 New
6,250 $589,000
Q1 2018

May 10, 2018

SELL
$77.67 - $92.63 $2.72 Million - $3.24 Million
-35,000 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$80.76 - $95.13 $4.04 Million - $4.76 Million
-50,000 Reduced 58.82%
35,000 $3.12 Million
Q3 2017

Nov 09, 2017

BUY
$80.6 - $94.95 $6.85 Million - $8.07 Million
85,000
85,000 $7.91 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.2B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.